The functions and regulation of the PTEN tumour suppressor
The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Abstract
The importance of the physiological function of phosphatase and tensin homologue (PTEN) is illustrated by its frequent disruption in cancer. By suppressing the phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway through its lipid phosphatase activity, PTEN governs a plethora of cellular processes including survival, proliferation, energy metabolism and cellular architecture. Consequently, mechanisms regulating PTEN expression and function, including transcriptional regulation, post-transcriptional regulation by non-coding RNAs, post-translational modifications and protein-protein interactions, are all altered in cancer. The repertoire of PTEN functions has recently been expanded to include phosphatase-independent activities and crucial functions within the nucleus. Our increasing knowledge of PTEN and pathologies in which its function is altered will undoubtedly inform the rational design of novel therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the majority of prostate cancer patients at presentation have lost one allele of PTEN while maintaining intact TP53; whereas TP53 mutations and the complete loss of PTEN are both associated with advanced stage prostate cancer 153,154”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [154]
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Self-citationAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Cited by
Items 901–1,000 of 1,010
Tetrandrine inhibits proliferation of colon cancer cells by BMP9/ PTEN/ PI3K/AKT signaling
Zhou, Y., Li, M., Liu, X., Li, Q., Ding, L.-X., Chen, H.-C., Hu, Y., Li, F., Sun, W., He, B., et al. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.10.017 · Cited by 27
miR‐520h Stimulates Drug Resistance to Paclitaxel by Targeting the OTUD3‐PTEN Axis in Breast Cancer
Geng, W., Song, H., Zhao, Q., Dong, K., Pu, Q., Gao, H., & Lv, Y. (2020) · BioMed Research International · doi:10.1155/2020/9512793 · Cited by 28
Signaling pathway dysregulation in breast cancer
Ryspayeva, D., Seyhan, A. A., MacDonald, W., Purcell, C., Roady, T. J., Ghandali, M., Verovkina, N., El‐Deiry, W. S., Taylor, M. S., & Graff, S. L. (2025) · Oncotarget · doi:10.18632/oncotarget.28701 · Cited by 33
Xue, P., Zheng, M., Diao, Z., Shen, L., Liu, M., Gong, P., Sun, H., & Hu, Y. (2013) · Placenta · doi:10.1016/j.placenta.2013.04.015 · Cited by 26
Li, J., Huang, W., Zhou, X., Chen, J., & Li, Z. (2019) · BMC Cancer · doi:10.1186/s12885-019-5605-5 · Cited by 26
RetractedSong, W., Zhang, J., Xia, Q., & Sun, M. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1671089 · Cited by 26
RetractedJiang, T., Feng, X., Zheng, F., Cui, X.-W., Lin, Y., Pan, Y., Yang, C., Ding, Z., Zhang, Y., Tan, Y., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.016 · Cited by 26
BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy
Chilamakuri, R., Rouse, D. C., Yu, Y., Kabir, A., Muth, A., Yang, J., Lipton, J. M., & Agarwal, S. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101272 · Cited by 28
Xing, C., Zhang, Y., Hu, W., & Zhao, L. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04376-1 · Cited by 26
Jiang, T., Cui, X.-W., Zeng, T., Pan, Y., Lin, Y., Feng, X., Tan, Y., Yuan, Z., Dong, L., & Wang, H. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.add7464 · Cited by 29
“1, D and E) than PTEN-positive patients, corroborating the notion that PTEN deficiency predicts rapid disease progression in human cancers in the absence of GEM treatment (24).”
BackgroundTranscription factors and cognate signalling cascades in the regulation of autophagy
Chandra, V., Bhagyaraj, E., Parkesh, R., & Gupta, P. (2016) · Biological Reviews · doi:10.1111/brv.12177 · Cited by 26
Bailón, E., Ugarte-Berzal, E., Amigo-Jiménez, I., den Steen, P. E. V., Opdenakker, G., Garcia-Marco, J. A., & Garcı́a-Pardo, A. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi0913-521r · Cited by 26
Genetic variation in AKT1, PTEN and the 8q24 locus, and the risk of testicular germ cell tumor
Andreassen, K. E., Kristiansen, W., Karlsson, R., Aschim, E. L., Dahl, O., Fosså, S. D., Adami, H., Wiklund, F. E., Haugen, T. B., & Grotmol, T. (2013) · Human Reproduction · doi:10.1093/humrep/det127 · Cited by 28
Chojnacka, K., Zarzycka, M., Hejmej, A., Mruk, D. D., Górowska-Wójtowicz, E., Kotula‐Balak, M., Klimek, M., & Bilińska, B. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.09.027 · Cited by 27
Prognostic role of PPAR-γ and PTEN in the renal cell carcinoma.
Zhu, C., Wei, J., Tian, X., Li, Y., & Li, X. (2015) · PubMed Central · Cited by 26
Maf1, A New PTEN Target Linking RNA and Lipid Metabolism
Johnson, D. L., & Stiles, B. L. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.04.016 · Cited by 28
Pharmacologic Targeting of S6K1 in PTEN-Deficient Neoplasia
Liu, H., Feng, X., Ennis, K. N., Behrmann, C. A., Sarma, P. N., Jiang, T. T., Kofuji, S., Niu, L., Stratton, Y., Thomas, H. E., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.022 · Cited by 29
Hu, J., Cao, X., Pang, D., Luo, Q., Zou, Y., Feng, B., Li, L., Chen, Z., & Huang, C. (2017) · Redox Biology · doi:10.1016/j.redox.2017.03.023 · Cited by 29
The role of PTEN - HCV core interaction in hepatitis C virus replication
Wu, Q., Li, Z.-B., Mellor, P., Zhou, Y., Anderson, D. H., & Liu, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-03052-w · Cited by 25
Fernandez, H. R., & Lindén, S. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-06149-4 · Cited by 26
Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer
Chen, S., Nimick, M., Cridge, A. G., Hawkins, B. C., & Rosengren, R. J. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4207 · Cited by 31
Preventive Inhibition of Liver Tumorigenesis by Systemic Activation of Innate Immune Functions
Lee, J., Liao, R., Wang, G., Yang, B.-H., Luo, X., Varki, N. M., Qiu, S., Ren, B., Fu, W., & Feng, G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.064 · Cited by 26
Maity, S., Das, F., Ghosh‐Choudhury, N., Kasinath, B. S., & Choudhury, G. G. (2019) · FEBS Letters · doi:10.1002/1873-3468.13505 · Cited by 28
Yang, J., Zhu, X.-J., Jin, M., Cao, Z., Ren, Y., & Gu, Z. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108934 · Cited by 30
Yoo, T.-K., Kim, J., & Hyun, T. K. (2020) · Plants · doi:10.3390/plants9060757 · Cited by 27
Expression of protein tyrosine phosphatases and Bombyx embryonic development
Gu, S., Chen, C., & Lin, P. (2021) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2021.104198 · Cited by 25
Alimohammadi, M., Rahimzadeh, P., Khorrami, R., Bonyadi, M., Daneshi, S., Nabavi, N., Raesi, R., Farani, M. R., Dehkhoda, F., Taheriazam, A., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155401 · Cited by 29
The paradox of elongation factor 4: highly conserved, yet of no physiological significance?
Zhang, D., & Qin, Y. (2013) · Biochemical Journal · doi:10.1042/bj20121792 · Cited by 27
Vuono, E. A., Mukherjee, A., Vierra, D. A., Adroved, M. M., Hodson, C., Deans, A. J., & Howlett, N. G. (2016) · Scientific Reports · doi:10.1038/srep36439 · Cited by 29
Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling
Wang, X., Lyu, J., Ji, A., Zhang, Q., & Liao, G. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.05.053 · Cited by 25
Gambogic acid affects ESCC progression through regulation of PI3K/AKT/mTOR signal pathway
Yu, J., Wang, W., Yao, W., Zhao, Y., Gao, P., Liu, M., Wang, H., Chen, S., Wang, D., Wang, W., et al. (2020) · Journal of Cancer · doi:10.7150/jca.41115 · Cited by 27
Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome
Smith, J. R., Liu, E., Church, A. J., Asch, E. A., Cherella, C. E., Srivastava, S., Kamihara, J., & Wassner, A. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa944 · Cited by 25
Zhao, Z., Xu, Q., Wei, R., Huang, L., Wang, W., Wei, G., & Ni, T. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab772 · Cited by 28
RSK1 promotes mammalian axon regeneration by inducing the synthesis of regeneration-related proteins
Mao, S., Chen, Y., Feng, W., Zhou, S., Jiang, C., Zhang, J., Liu, X., Qian, T., Liu, K., Wang, Y., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001653 · Cited by 23
Kluck, G. E. G., Qian, A. S., Sakarya, E. H., Quach, H., Deng, Y. D., & Trigatti, B. L. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318062 · Cited by 30
Luo, J., Li, H., Xiu, J., Zeng, J., Feng, Z., Zhao, H., Li, Y., & Wei, W. (2023) · Biomarker Research · doi:10.1186/s40364-023-00471-y · Cited by 25
Matsushima‐Nishiwaki, R., Kumada, T., Nagasawa, T., Suzuki, M., Yasuda, E., Okuda, S., Maeda, A., Kaneoka, Y., Toyoda, H., & Kozawa, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078440 · Cited by 26
“PTEN negatively regulates the AKT activity at a point upstream of AKT, and the loss of PTEN function leads to the constitutive activation of the PI3K-AKT pathway [17].”
InfluentialSparks, J. D., O’Dell, C., Chamberlain, J. M., & Sparks, C. E. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.029 · Cited by 25
Pharmacogenomics of EGFR-targeted therapies in non–small cell lung cancer: EGFR and beyond
Delaney, C. D., Frank, S., & Huang, R. S. (2015) · 癌症:英文版 · doi:10.1186/s40880-015-0007-9 · Cited by 29
A Drosophila ‐centric view of protein tyrosine phosphatases
Hatzihristidis, T., Desai, N., Hutchins, A. P., Meng, T., Tremblay, M. L., & Miranda‐Saavedra, D. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.03.005 · Cited by 26
Rab5 and Ndfip1 Are Involved in Pten Ubiquitination and Nuclear Trafficking
Li, Y., Low, L., Putz, U., Goh, C., Tan, S., & Howitt, J. A. (2014) · Traffic · doi:10.1111/tra.12175 · Cited by 24
Zhang, L., Ma, T., Brozick, J., Babalola, K., Budiu, R. A., Tseng, G. C., & Vlad, A. (2016) · Oncogene · doi:10.1038/onc.2016.53 · Cited by 27
Kim, M. S., El‐Fiqi, A., Kim, J., Ahn, H.-S., Kim, H., Son, Y., Kim, H., & Hyun, J. K. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b06889 · Cited by 25
Noguera, N. I., Piredda, M. L., Taulli, R., Catalano, G., Angelini, G., Gaur, G., Nervi, C., Voso, M. T., Lunardi, A., Pandolfi, P. P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11964 · Cited by 27
Self-citationMTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity
Si, W., Liu, X., Wei, R., Zhang, Y., Zhao, Y., Cui, L., & Hong, T. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1424-5 · Cited by 27
Chen, Y., Chen, C., Polci, R., Wei, R. L.-H., Riley, D. J., & Chen, P. (2014) · Oncotarget · doi:10.18632/oncotarget.2005 · Cited by 25
Wang, Q., Liu, X., Zhou, J., Huang, Y., Zhang, S., Shen, J., Loera, S., Yuan, X., Chen, W., Jin, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070191 · Cited by 25
Yang, C., Huang, X., Liu, H., Xiao, F., Wei, J., You, L., & Qian, W. (2017) · Oncotarget · doi:10.18632/oncotarget.16642 · Cited by 31
Wong, C. W., Or, P. M. Y., Wang, Y., Li, L., Li, J., Yan, M., Cao, Y., Luk, H., Tong, T. M. F., Leslie, N. R., et al. (2018) · Autism Research · doi:10.1002/aur.1950 · Cited by 24
A pathogenic role for germline PTEN variants which accumulate into the nucleus
Mingo, J., Rodríguez‐Escudero, I., Luna, S., Fernández‐Acero, T., Amo, L., Jonasson, A. R., Zori, R. T., Lopez, J. I., Molina, M., Cid, V. J., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0155-x · Cited by 27
Hsa_circ_0033155: A potential novel biomarker for non‑small cell lung cancer
Gu, X., Wang, G., Shen, H., & Fei, X. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6565 · Cited by 24
Barata, P. C., Cooney, M. M., Mendiratta, P., Gupta, R., Dreicer, R., & Garcia, J. A. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0687-5 · Cited by 24
Tan, Y., Shudo, T., Yoshida, T., Sugiyama, Y., Jia, Y., Tsukano, C., Takemoto, Y., & Kakizuka, A. (2019) · Genes to Cells · doi:10.1111/gtc.12719 · Cited by 26
Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations
Kingston, B., Bailleux, C., Delaloge, S., Schiavon, G., Scott, V., Lacroix‐Triki, M., Carr, T. H., Kozarewa, I., Gevensleben, H., Kemp, Z., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.19.00130 · Cited by 24
Wu, C., Ruan, Y., Zhao, S., Ning, J., Rao, T., Yu, W., Zhou, X., Liu, C., Qi, Y., & Fan, C. (2019) · Europe PMC (PubMed Central) · Cited by 24
Proteomic and transcriptomic profiling of Pten gene‐knockout mouse model of prostate cancer
Zhang, J., Kim, S., Li, L., Kemp, C. J., Jiang, C., & Lü, J. (2020) · The Prostate · doi:10.1002/pros.23972 · Cited by 26
Kato, T., Yamada, T., Nakamura, H., Igarashi, A., Anders, R. A., Sesaki, H., & Iijima, M. (2020) · iScience · doi:10.1016/j.isci.2020.101548 · Cited by 26
PTEN Lipid Phosphatase Activity Enhances Dengue Virus Production through Akt/FoxO1/Maf1 Signaling
Liu, B., Gao, T., Fu, X., Xu, Z.-H., Ren, H., Zhao, P., Qi, Z., & Qin, Z.-L. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00291-6 · Cited by 27
Sun, M., He, X., Huang, P.-Y., Qi, Q., Sun, W., Liu, G.-S., & Hua, J. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i38.5822 · Cited by 26
Hepatic HuR Protects Against the Pathogenesis of Non-Alcoholic Fatty Liver Disease
Tian, M., Wang, J., Liu, S., Li, X., Li, J., Yang, J., Zhang, C., & Zhang, W. (2020) · Cell Death and Disease · doi:10.1038/s41419-021-03514-0 · Cited by 26
Zhao, Y., Gao, L., Jiang, C., Chen, J., Qin, Z., Zhong, F., Yan, Y., Tong, R., Zhou, M., Yuan, A., et al. (2022) · Hepatology · doi:10.1002/hep.32165 · Cited by 24
Ren, D., Sun, Y., Li, D., Wu, H., & Jin, X. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13137 · Cited by 26
Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma
Davidson, S. M., Heyman, J. E., O’Brien, J. P., Liu, A. C., Schmidt, D. R., Israelsen, W. J., Dayton, T. L., Sehgal, R., Bronson, R. T., Freinkman, E., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2352 · Cited by 30
Self-citationLiu, Y., Wang, J., Chen, J., Wu, S., Zeng, X., Xiong, Q., Guo, Y., Sun, J., Song, F., Xu, J., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.05.031 · Cited by 24
The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets
Liu, J., Pan, Y., Liu, Y., Wei, W., Hu, X., Xin, W., & Chen, N. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31053 · Cited by 28
“tional, posttranscriptional, and posttranslational levels (including protein–protein interactions and posttranslational modifications) (Shi et al., 2012; Song et al., 2012).”
BackgroundSusceptibility Genes Associated with Multiple Primary Cancers
Lu, M., Zhang, X., Chu, Q., Chen, Y., & Zhang, P. (2023) · Cancers · doi:10.3390/cancers15245788 · Cited by 30
“Within this pathway, PTEN (Phosphatase and Tensin Homolog) acts as a tumor suppressor gene, ensuring the orderly regulation of cell survival and proliferation processes [79].”
BackgroundFBXO32-mediated degradation of PTEN promotes lung adenocarcinoma progression
Wu, J., Wen, T., Marzio, A., Song, D., Chen, S., Yang, C., Zhao, F., Zhang, B., Zhao, G. S., Ferri, A., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06635-4 · Cited by 25
“All cells were authenticated by STR pro fi ling and tested for mycoplasma contamination.”
Morgana acts as a proto‐oncogene through inhibition of a ROCK–PTEN pathway
Fusella, F., Ferretti, R., Recupero, D., Rocca, S., Savino, A. D., Tornillo, G., Silengo, L., Turco, E., Cabodi, S., Provero, P., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4341 · Cited by 24
Self-citationZhang, X., Chen, X., Zhai, Y., Cui, Y., Cao, P., Zhang, H., Wu, Z., Li, P., Yu, L., Xia, X., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092135 · Cited by 26
PTEN dampens PIP3 upregulation in spines during NMDA receptor-dependent long-term depression
Arendt, K. L., Benoist, M., Lario, A., Draffin, J. E., Muñoz, M.-D., & Esteban, J. A. (2014) · Journal of Cell Science · doi:10.1242/jcs.156554 · Cited by 29
Liu, Y., Hao, S., Yu, L., & Gao, Z. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0558-x · Cited by 29
Zeng, Y., Fu, M., Wu, G.-W., Zhang, A.-Z., Chen, J., Lin, H., Fu, Y., Jia, J., Cai, Z., Wu, X., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3642 · Cited by 25
Zhu, Y.-T., Wu, Y.-X., Shi, W.-H., Wang, J., Yan, X., Wang, Q.-T., Liu, Y., Yang, L., Gao, L., & Li, M.-X. (2017) · Life Science · doi:10.1016/j.lfs.2017.02.007 · Cited by 23
Bayesian graphical models for computational network biology
Ni, Y., Müller, P., Wei, L., & Ji, Y. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2063-z · Cited by 33
EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients
Lu, H., Qin, J., Han, N., Lei, L., Xie, F., & Li, C. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s159612 · Cited by 24
MiR-4465 directly targets PTEN to inhibit AKT/mTOR pathway–mediated autophagy
Tao, Z., Feng, C., Mao, C., Ren, J., Tai, Y., Guo, H., Pu, M., Zhou, Y., Wang, G., & Wang, M. (2018) · Cell Stress and Chaperones · doi:10.1007/s12192-018-0946-6 · Cited by 24
Harris, L. J., Hughes, K. L., Ehrhart, E. J., Labadie, J., Yoshimoto, J. A., & Avery, A. C. (2019) · Veterinary and Comparative Oncology · doi:10.1111/vco.12460 · Cited by 29
Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia
Richter, A. M., Roolf, C., Hamed, M., Gladbach, Y. S., Sender, S., Konkolefski, C., Knuebel, G., Sekora, A., Fuellen, G., Vollmar, B., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5411-0 · Cited by 24
miR-19 promotes the proliferation of clear cell renal cell carcinoma by targeting the FRK–PTEN axis
Jing, Z., Bi, J., Li, Z., Liu, X., Li, J., Zhu, Y., Zhang, X., Zhang, Z., Li, Z.-H., & Kong, C. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s199238 · Cited by 24
Su, K., & Yu, Y. (2019) · Cancers · doi:10.3390/cancers11081065 · Cited by 25
“PTEN is one of the most common tumor suppressors, and mutations in or deletions of PTEN are frequently found in various human cancers and promote tumorigenesis [30].”
Wang, J., Ren, D.-P., Sun, Y., Xu, C., Wang, C., Cheng, R., Wang, L., Jia, G., Ren, J., Ma, J., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14996 · Cited by 25
The Absence of PTEN in Breast Cancer Is a Driver of MLN4924 Resistance
Du, M., Peng, Z., Gai, W., Liu, F., Liu, W., Chen, Y., Li, H., Zhang, X., Liu, C. H., Zhang, L.-Q., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.667435 · Cited by 25
Prostate Cancer: A Review of Genetics, Current Biomarkers and Personalised Treatments
Wilson, T. K., & Zishiri, O. T. (2024) · Cancer Reports · doi:10.1002/cnr2.70016 · Cited by 61
“…would be no PTEN present to convert PIP 3 into PIP 2 , which would cause phosphorylated AKT to modify downstream targets, such as the mTOR signalling cascade, resulting in uncontrolled cellular function regulations, including cellular differentiation, proliferation, growth and apoptosis [112].”
Hou, G., Yang, S., Zhou, Y., Wang, C., Zhao, W. H., & Lu, Z. (2014) · Journal of Immunology Research · doi:10.1155/2014/845763 · Cited by 26
Najem, S. A., Khawaja, G., Hodroj, M. H., & Rizk, S. E. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467212666190313154531 · Cited by 25
LncRNA SNHG4 regulates miR-10a/PTEN to inhibit the proliferation of acute myeloid leukemia cells
Yuan, Z., & Wang, W. (2020) · Hematology · doi:10.1080/16078454.2020.1754636 · Cited by 24
Sharma, A. K., Sun, J., Singaram, I., Ralko, A. A., Lee, D., & Cho, W. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00241 · Cited by 23
A Tumor Suppressor Enhancer of PTEN in T-cell Development and Leukemia
Tottone, L., Lancho, O., Loh, J.-W., Singh, A., Kimura, S., Roels, J., Kuchmiy, A. A., Strubbe, S., Lawlor, M. A., da Silva-Diz, V., et al. (2020) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0201 · Cited by 42
A key driver to promote HCC: Cellular crosstalk in tumor microenvironment
Liu, P., Lingyu, K., Liu, Y., Li, G., Xie, J., & Lu, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1135122 · Cited by 30
“For example, phosphatase and tensin homolog on chromosome ten (PTEN) inhibits the activation of PI3K signaling, and downregulation or deletion of PTEN leads to increasing PI3K-AKT pathway activity in multiple cancers, including HCC, thus accelerating tumor malignant progression (44, 45).”
BackgroundBrain patterning perturbations following PTEN loss
Veleva-Rotse, B. O., & Barnes, A. P. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00035 · Cited by 24
Kiselev, V. Y., Juvin, V., Malek, M., Luscombe, N. M., Hawkins, P. T., Novère, N. G. L., & Stephens, L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1015 · Cited by 30
Bi, L., Yan, X., Yang, Y., Lei, Q., Tian, Y., Mao, J., & Chen, W. (2017) · Oncotarget · doi:10.18632/oncotarget.21354 · Cited by 23
Wijayatunga, N. N., Pahlavani, M., Kalupahana, N. S., Kottapalli, K. R., Gunaratne, P. H., Coarfa, C., Ramalingam, L., & Moustaïd‐Moussa, N. (2018) · Oncotarget · doi:10.18632/oncotarget.24226 · Cited by 26
Tsuji‐Tamura, K., & Ogawa, M. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.080 · Cited by 23
Yin, J., Li, X., Zhang, Z., Luo, X., Wang, L., & Liu, L. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4390 · Cited by 25
The Lipid Side of Bone Marrow Adipocytes: How Tumor Cells Adapt and Survive in Bone
Diedrich, J. D., Herroon, M. K., Rajagurubandara, E. N., & Podgorski, I. (2018) · Current Osteoporosis Reports · doi:10.1007/s11914-018-0453-9 · Cited by 27
Breuksch, I., Welter, J., Bauer, H., Enklaar, T., Frees, S., Thüroff, J. W., Hasenburg, A., Prawitt, D., & Brenner, W. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0247-9 · Cited by 23
Bertacchini, J., Mediani, L., Beretti, F., Guida, M., Ghalali, A., Brugnoli, F., Bertagnolo, V., Petricoin, E., Potì, F., Arioli, J., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27768 · Cited by 24
Wang, M., Qiu, R., Gong, Z., Zhao, X., Wang, T., Zhou, L., Lu, W., Shen, B., Zhu, W., & Xu, W. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28764 · Cited by 23
MiR-301a Promotes Cell Proliferation by Repressing PTEN in Renal Cell Carcinoma
Li, J., Jiang, D., Zhang, Q., Peng, S., Liao, G., Yang, X., Tang, J., Xiong, H., & Pang, J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s253533 · Cited by 25
Metadata
- Authors
- Song, M. S., Salmena, L., & Pandolfi, P. P.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Song, Min Sup
- Salmena, Leonardo
- Pandolfi, Pier Paolo
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-04-04
- Volume
- 13
- Issue
- 5
- Pages
- 283-296
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2017739035
- Cited by
- 1,926
- References
- 159
- Citations by year
- 2026: 50 · 2025: 81 · 2024: 85 · 2023: 100 · 2022: 124 · 2021: 113 · 2020: 147 · 2019: 155 · 2018: 172 · 2017: 183 · 2016: 167 · 2015: 182 · 2014: 199 · 2013: 136 · 2012: 31
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Cancer Institute (R01 CA-82328-09, R01CA082328)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- PTEN, phosphatase and tensin homologue, tumour suppressor, PI3K/AKT/mTOR pathway, lipid phosphatase activity, transcriptional regulation, non-coding RNA, post-translational modification, protein-protein interaction, cancer therapy, energy metabolism, cell proliferation
- MeSH terms
- Animals, Cell Nucleus, Gene Expression Regulation, Humans, Mutation, Neoplasms, Protein Conformation, Neoplastic Stem Cells, Signal Transduction, Tumor Suppressor Proteins, PTEN Phosphohydrolase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.